The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types
The prognostic value of PD-L1 expression in both IC and TC differs between antibody clones, with 73-10 and SP263 being more reliable for prognostic information than 22C3 in resected CRC.
Authors
- Helga Hagman (ORCID: https://orcid.org/0000-0002-4427-1123)
- Karin Jirström (ORCID: https://orcid.org/0000-0003-2257-5000)
- Hans Brunnström (ORCID: https://orcid.org/0000-0001-7402-138X)
- Stina Garvin
- Björn Nodin
- Hampus Nobin
Institutions
- Linköping University (SE)
- Lund University (SE)
- Skåne University Hospital (SE)
- Landstinget i Kalmar län (SE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s12885-024-12812-7
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Cancerfonden
- Lunds Universitet